Canon U.S.A. announced Thursday it has made a strategic investment in Ottawa-based Spartan Bioscience Inc. to fund research and development of new diagnostic testing products.
Canon’s wholly-owned subsidiary, Canon BioMedical Inc. is looking into ways it can work with Spartan on other products like rapid genetic testing.
“We are excited to continue our efforts as we move into new markets for rapid genetic testing,” Spartan CEO Paul Lem said in a statement. “Working with Canon will help accelerate our progress in the future.”
OBJ360 (Sponsored)
SnowBall: A Cool Winter’s Eve to Keep Ottawa Kids Warm This Winter
As Ottawa’s winter chill sets in, the warmth of community spirit takes centre stage at SnowBall: A Cool Winter’s Eve, The Snowsuit Fund’s sought-after gala happening at the Ottawa Art
Prince Edward Island wants you to experience a different kind of winter
Prince Edward Island (PEI) is a special place in the minds of visitors, known for its iconic landscapes, traditions and characters. Whether it’s the red soil and rolling hills, sandy
Seymour Liebman, who currently sits on Canon BioMedical’s board of directors will also join Spartan’s board.
“Spartan’s goals align with our mission to provide enhanced diagnostic testing systems that can help improve human health worldwide,” Mr. Liebman said in a statement.
Terms of the investment were not disclosed.
